Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Samantha MaWhinney

Concepts (515)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
91
2026
3195
4.630
 Why?
Anti-HIV Agents
41
2026
912
3.970
 Why?
Adenine
18
2026
339
2.730
 Why?
Tenofovir
20
2026
301
2.570
 Why?
Dried Blood Spot Testing
10
2026
126
2.200
 Why?
Organophosphates
15
2026
179
1.920
 Why?
Emtricitabine
16
2025
210
1.910
 Why?
Acquired Immunodeficiency Syndrome
10
2023
237
1.500
 Why?
HIV-1
31
2021
908
1.400
 Why?
Patient Dropouts
3
2025
66
1.060
 Why?
Viral Load
21
2026
526
0.820
 Why?
Medication Adherence
12
2025
540
0.810
 Why?
Pre-Exposure Prophylaxis
8
2025
269
0.790
 Why?
Drug Monitoring
7
2024
401
0.670
 Why?
Frailty
4
2026
205
0.640
 Why?
High-Intensity Interval Training
3
2026
45
0.630
 Why?
Viremia
7
2026
160
0.600
 Why?
Middle Aged
72
2026
36309
0.550
 Why?
Aging
10
2026
1973
0.530
 Why?
Directly Observed Therapy
1
2017
16
0.530
 Why?
Adult
65
2026
40881
0.500
 Why?
Humans
133
2026
145783
0.480
 Why?
Male
85
2026
73010
0.470
 Why?
Anti-Retroviral Agents
5
2019
251
0.460
 Why?
Pulmonary Disease, Chronic Obstructive
1
2023
920
0.460
 Why?
Leukocytes, Mononuclear
9
2021
574
0.440
 Why?
Female
83
2026
79045
0.430
 Why?
Exercise
7
2026
2205
0.420
 Why?
Exercise Therapy
4
2026
475
0.410
 Why?
Zidovudine
3
2012
77
0.410
 Why?
Lamivudine
3
2012
65
0.410
 Why?
Body Composition
5
2026
693
0.400
 Why?
Unsafe Sex
2
2012
61
0.390
 Why?
Cytochrome P-450 CYP3A
2
2012
93
0.370
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
2025
19
0.370
 Why?
CD8-Positive T-Lymphocytes
9
2018
923
0.350
 Why?
Sofosbuvir
4
2022
61
0.350
 Why?
T-Lymphocytes, Cytotoxic
6
2014
177
0.350
 Why?
Oligopeptides
2
2012
267
0.340
 Why?
Cohort Studies
10
2026
6033
0.330
 Why?
Atazanavir Sulfate
4
2016
42
0.320
 Why?
Models, Statistical
5
2022
672
0.310
 Why?
Sustained Virologic Response
3
2019
46
0.310
 Why?
HIV Integrase Inhibitors
2
2024
79
0.310
 Why?
Prospective Studies
23
2022
8078
0.310
 Why?
Receptors, CCR5
6
2013
60
0.310
 Why?
Sarcopenia
2
2026
91
0.300
 Why?
Dideoxynucleotides
2
2012
16
0.300
 Why?
Mobile Applications
2
2022
199
0.300
 Why?
Cytidine Triphosphate
2
2012
19
0.300
 Why?
Phosphorous Acids
2
2019
15
0.300
 Why?
CD4-Positive T-Lymphocytes
9
2016
1146
0.300
 Why?
Levonorgestrel
2
2012
34
0.290
 Why?
Emigrants and Immigrants
1
2012
158
0.290
 Why?
Pyridines
2
2012
609
0.280
 Why?
Antiviral Agents
3
2019
769
0.280
 Why?
Sarcoma, Kaposi
3
2022
83
0.270
 Why?
Antiretroviral Therapy, Highly Active
8
2019
279
0.270
 Why?
Aged
29
2026
26217
0.270
 Why?
Longitudinal Studies
7
2025
2968
0.260
 Why?
Quality of Life
7
2023
3211
0.250
 Why?
Lymphocyte Activation
10
2018
1133
0.250
 Why?
Gonadal Steroid Hormones
1
2008
143
0.250
 Why?
Deoxyadenine Nucleotides
2
2016
15
0.250
 Why?
Deoxycytosine Nucleotides
2
2016
13
0.250
 Why?
Creutzfeldt-Jakob Syndrome
1
2006
19
0.240
 Why?
Prion Diseases
1
2006
21
0.240
 Why?
Wasting Disease, Chronic
1
2006
36
0.240
 Why?
Data Interpretation, Statistical
2
2025
368
0.230
 Why?
Lymph Nodes
6
2017
509
0.230
 Why?
Coronary Artery Bypass
8
2004
268
0.230
 Why?
Inflammation
5
2021
2884
0.230
 Why?
Gene Expression
2
2014
1478
0.230
 Why?
Simian Immunodeficiency Virus
2
2016
93
0.220
 Why?
Young Adult
17
2025
14254
0.220
 Why?
Bias
2
2025
197
0.220
 Why?
Simian Acquired Immunodeficiency Syndrome
2
2016
92
0.220
 Why?
CD4 Lymphocyte Count
11
2020
280
0.220
 Why?
Contraceptives, Postcoital
1
2004
2
0.210
 Why?
HIV
4
2019
251
0.210
 Why?
Computer Simulation
4
2025
1003
0.200
 Why?
Cross-Over Studies
4
2020
610
0.200
 Why?
Population Surveillance
3
2002
484
0.200
 Why?
Cytokines
3
2009
2069
0.200
 Why?
Physical Fitness
2
2015
207
0.200
 Why?
Advance Care Planning
2
2021
244
0.190
 Why?
Lipopolysaccharide Receptors
2
2021
88
0.190
 Why?
HIV Integrase
1
2024
74
0.190
 Why?
Fluorenes
2
2020
45
0.190
 Why?
HIV Seropositivity
3
2012
119
0.180
 Why?
Drug Resistance, Viral
2
2019
126
0.180
 Why?
Cell Phone
1
2022
82
0.180
 Why?
Lymphoid Tissue
3
2008
78
0.170
 Why?
Hepatitis C
2
2022
256
0.170
 Why?
Telerehabilitation
1
2022
49
0.170
 Why?
RNA, Viral
9
2014
693
0.170
 Why?
Benzimidazoles
2
2020
189
0.170
 Why?
Hair
2
2018
84
0.170
 Why?
Protease Inhibitors
2
2020
102
0.170
 Why?
Alanine
4
2024
169
0.170
 Why?
Fees and Charges
1
2000
12
0.160
 Why?
Ritonavir
2
2012
75
0.160
 Why?
Polyphosphates
4
2022
43
0.160
 Why?
Hyperlipidemias
1
2021
120
0.160
 Why?
Interleukin-10
2
2021
311
0.160
 Why?
Mitochondria, Muscle
1
2021
120
0.150
 Why?
Research Design
2
2025
1139
0.150
 Why?
Advance Directives
1
2021
88
0.150
 Why?
Costs and Cost Analysis
1
2000
221
0.150
 Why?
ADP-ribosyl Cyclase 1
4
2013
43
0.150
 Why?
Thymine Nucleotides
2
2016
19
0.140
 Why?
Biomarkers
7
2021
4302
0.140
 Why?
Hepatitis C, Chronic
2
2019
153
0.140
 Why?
Cytomegalovirus Infections
2
2015
206
0.140
 Why?
Myocardial Ischemia
1
2000
285
0.140
 Why?
Blood Chemical Analysis
4
2019
109
0.140
 Why?
Simeprevir
1
2018
5
0.140
 Why?
Colorado
7
2022
4556
0.130
 Why?
Raltegravir Potassium
2
2015
18
0.130
 Why?
Virus Replication
5
2017
521
0.130
 Why?
Heterocyclic Compounds, 3-Ring
1
2018
44
0.130
 Why?
Epitopes, T-Lymphocyte
4
2008
174
0.130
 Why?
Transgender Persons
1
2021
210
0.130
 Why?
Viral Tropism
1
2017
36
0.130
 Why?
Pharmacogenetics
2
2016
175
0.130
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2021
444
0.120
 Why?
AIDS-Related Opportunistic Infections
3
2007
130
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2017
132
0.120
 Why?
Pyrophosphatases
1
2016
26
0.120
 Why?
Deoxyguanine Nucleotides
1
2016
12
0.120
 Why?
Lung
3
2026
4116
0.120
 Why?
Motor Activity
4
2015
718
0.120
 Why?
Genitalia
1
2016
33
0.120
 Why?
Length of Stay
4
2000
1350
0.120
 Why?
Sleep Wake Disorders
1
2020
314
0.120
 Why?
Time Factors
9
2026
7134
0.120
 Why?
Germinal Center
1
2016
64
0.120
 Why?
Ribavirin
1
2016
81
0.120
 Why?
Academic Medical Centers
1
2019
554
0.120
 Why?
Vaccines, DNA
2
2008
32
0.120
 Why?
HIV Protease Inhibitors
2
2016
69
0.120
 Why?
AIDS Vaccines
2
2008
53
0.120
 Why?
Purines
1
2016
187
0.110
 Why?
Muscle Strength
1
2018
332
0.110
 Why?
Disease Transmission, Infectious
2
2018
69
0.110
 Why?
T-Lymphocyte Subsets
4
2015
420
0.110
 Why?
Risk Factors
11
2021
10919
0.110
 Why?
Biometry
2
2011
66
0.110
 Why?
HLA-DR Antigens
3
2012
220
0.110
 Why?
Case-Control Studies
7
2016
3634
0.110
 Why?
Genitalia, Female
1
2015
42
0.110
 Why?
Rectum
1
2016
182
0.110
 Why?
Antibodies, Viral
3
2015
674
0.110
 Why?
Linear Models
4
2020
849
0.110
 Why?
Organophosphonates
1
2015
95
0.110
 Why?
Probability
2
2011
308
0.100
 Why?
Calcifediol
1
2014
31
0.100
 Why?
Mental Health Services
1
2019
475
0.100
 Why?
T-Lymphocytes, Regulatory
1
2017
411
0.100
 Why?
Calcitriol
1
2014
58
0.100
 Why?
Immunoglobulin Variable Region
1
2014
80
0.100
 Why?
Deoxycytidine
1
2015
220
0.100
 Why?
Antimicrobial Cationic Peptides
1
2014
81
0.100
 Why?
Membrane Glycoproteins
3
2013
499
0.100
 Why?
Disease Progression
4
2015
2865
0.100
 Why?
Microbiota
1
2021
730
0.100
 Why?
Multivariate Analysis
8
2007
1547
0.100
 Why?
Patient Compliance
1
2017
588
0.100
 Why?
Resistance Training
2
2026
186
0.100
 Why?
Sexual and Gender Minorities
1
2017
265
0.100
 Why?
Telemedicine
1
2022
967
0.100
 Why?
Decision Making
1
2021
982
0.100
 Why?
Chromatography, Liquid
3
2019
450
0.100
 Why?
Immunoglobulin G
2
2015
892
0.090
 Why?
Gastrointestinal Microbiome
1
2021
768
0.090
 Why?
Adolescent
14
2020
22577
0.090
 Why?
Hand Strength
2
2026
144
0.090
 Why?
Immunologic Factors
1
2015
260
0.090
 Why?
Infectious Disease Transmission, Vertical
1
1994
194
0.090
 Why?
Spleen
1
2014
508
0.090
 Why?
Hepatitis A Vaccines
1
2012
19
0.090
 Why?
Hepatitis A
1
2012
25
0.090
 Why?
Benzoxazines
1
2012
31
0.090
 Why?
Dendritic Cells
2
2008
501
0.090
 Why?
Numerical Analysis, Computer-Assisted
2
2002
19
0.090
 Why?
Diabetes Mellitus
1
2020
1101
0.090
 Why?
Cervix Uteri
1
2012
50
0.090
 Why?
Cell Movement
3
2016
963
0.090
 Why?
Tandem Mass Spectrometry
3
2019
572
0.090
 Why?
Marijuana Smoking
1
2015
249
0.090
 Why?
Emergency Service, Hospital
1
2004
2383
0.090
 Why?
Contraceptive Agents
1
2012
66
0.090
 Why?
Benchmarking
2
2024
191
0.090
 Why?
Haplotypes
2
2012
500
0.090
 Why?
Polymorphism, Genetic
2
2016
615
0.090
 Why?
B-Lymphocytes
1
2016
872
0.080
 Why?
CD4 Antigens
1
2011
137
0.080
 Why?
Muscle, Skeletal
1
2021
1791
0.080
 Why?
Contraceptive Agents, Female
1
2012
80
0.080
 Why?
Sex Factors
5
2018
2110
0.080
 Why?
HIV Seronegativity
1
2010
29
0.080
 Why?
Antacids
1
2010
16
0.080
 Why?
Fatigue
2
2026
366
0.080
 Why?
Pyrrolidinones
1
2010
29
0.080
 Why?
Hypertension, Pulmonary
1
2022
1957
0.080
 Why?
Mental Disorders
1
2019
1171
0.080
 Why?
Retrospective Studies
9
2021
17330
0.080
 Why?
Osteoporosis
1
2013
239
0.080
 Why?
Frail Elderly
2
2026
136
0.080
 Why?
Treatment Outcome
11
2026
11794
0.080
 Why?
Herpesvirus 8, Human
2
2000
67
0.080
 Why?
Phenotype
5
2026
3170
0.080
 Why?
Diphosphates
2
2021
20
0.080
 Why?
Postmenopause
1
2012
394
0.080
 Why?
Accidental Falls
1
2012
230
0.070
 Why?
Predictive Value of Tests
4
2019
2123
0.070
 Why?
Cross-Sectional Studies
8
2019
5925
0.070
 Why?
Pyridones
2
2024
209
0.070
 Why?
Cytomegalovirus
2
2015
168
0.070
 Why?
Drug Interactions
3
2019
405
0.070
 Why?
Molecular Sequence Data
3
2009
2883
0.070
 Why?
Zimbabwe
3
2022
76
0.070
 Why?
Age Factors
4
2026
3346
0.070
 Why?
Complementarity Determining Regions
2
2014
54
0.070
 Why?
Cytotoxicity Tests, Immunologic
3
2003
39
0.070
 Why?
Polymorphism, Single Nucleotide
2
2016
2181
0.070
 Why?
Sequence Analysis, DNA
2
2009
778
0.070
 Why?
Demography
2
2022
282
0.070
 Why?
Hepacivirus
2
2022
242
0.070
 Why?
Lung Diseases
1
2015
782
0.070
 Why?
Mutation
2
2014
4090
0.070
 Why?
Healthy Volunteers
2
2018
219
0.070
 Why?
Plasma
1
2009
223
0.070
 Why?
Absorptiometry, Photon
2
2026
277
0.060
 Why?
Interleukin-12
2
1998
115
0.060
 Why?
Hospitals, Veterans
3
2004
258
0.060
 Why?
Managed Care Programs
1
2007
140
0.060
 Why?
Adipocytes
1
2008
223
0.060
 Why?
Deer
1
2006
43
0.060
 Why?
Interferon-gamma
3
2008
784
0.060
 Why?
Comorbidity
3
2019
1662
0.060
 Why?
Physicians, Family
1
2007
177
0.060
 Why?
Therapeutic Equivalency
2
2018
31
0.060
 Why?
Self Report
2
2021
876
0.060
 Why?
Preventive Health Services
1
2007
153
0.060
 Why?
Interleukin-6
2
2021
780
0.060
 Why?
Kenya
1
2025
129
0.050
 Why?
Macaca mulatta
2
2016
186
0.050
 Why?
Flow Cytometry
4
2015
1165
0.050
 Why?
Forced Expiratory Volume
1
2026
450
0.050
 Why?
T-Lymphocytes
3
2005
1998
0.050
 Why?
Immunoenzyme Techniques
1
2005
200
0.050
 Why?
Incidence
4
2012
2934
0.050
 Why?
Licensure, Pharmacy
1
2004
1
0.050
 Why?
Area Under Curve
2
2018
332
0.050
 Why?
Northern Ireland
1
2004
12
0.050
 Why?
Immunologic Memory
2
2009
368
0.050
 Why?
Geriatric Assessment
1
2026
240
0.050
 Why?
Respiratory Function Tests
1
2026
544
0.050
 Why?
New York City
2
1994
85
0.050
 Why?
Odds Ratio
3
2014
1083
0.050
 Why?
Fluorescent Antibody Technique
3
2015
365
0.050
 Why?
Programmed Cell Death 1 Receptor
2
2016
266
0.050
 Why?
HIV Antibodies
2
2014
61
0.050
 Why?
Survival Analysis
3
2015
1378
0.050
 Why?
Pilot Projects
3
2022
1898
0.050
 Why?
Conserved Sequence
1
2003
244
0.050
 Why?
Hospitalization
3
2022
2461
0.050
 Why?
Ki-67 Antigen
2
2017
118
0.050
 Why?
Integrases
1
2024
122
0.050
 Why?
Patient Satisfaction
1
2007
712
0.050
 Why?
Surveys and Questionnaires
2
2014
6085
0.050
 Why?
Reverse Transcriptase Inhibitors
1
2002
87
0.050
 Why?
Tablets
1
2022
41
0.050
 Why?
Creatinine
3
2018
515
0.050
 Why?
Quality of Health Care
1
2007
693
0.050
 Why?
Likelihood Functions
3
2001
138
0.050
 Why?
Cells, Cultured
4
2017
4151
0.050
 Why?
Triazoles
1
2024
191
0.050
 Why?
Drug Therapy, Combination
2
2018
1043
0.040
 Why?
Models, Biological
2
2016
1764
0.040
 Why?
Bayes Theorem
2
2020
421
0.040
 Why?
Habits
1
2022
52
0.040
 Why?
Drug Prescriptions
1
2004
288
0.040
 Why?
Voltage-Dependent Anion Channel 1
1
2021
15
0.040
 Why?
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
1
2021
39
0.040
 Why?
Angina Pectoris
1
2001
76
0.040
 Why?
Citrate (si)-Synthase
1
2021
57
0.040
 Why?
Sex Characteristics
1
2007
789
0.040
 Why?
Antigens, Viral
3
2014
182
0.040
 Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
41
0.040
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
80
0.040
 Why?
Mental Health
2
2019
796
0.040
 Why?
Diagnosis-Related Groups
1
2000
35
0.040
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.040
 Why?
Hemarthrosis
1
2000
22
0.040
 Why?
HIV Antigens
2
2015
17
0.040
 Why?
Heart Valves
1
2000
44
0.040
 Why?
Death
1
2021
132
0.040
 Why?
Weight Gain
1
2024
561
0.040
 Why?
Actigraphy
1
2020
148
0.040
 Why?
Communicable Diseases
1
2002
166
0.040
 Why?
Virus Diseases
1
2002
216
0.040
 Why?
Weight Loss
2
2020
859
0.040
 Why?
Superoxide Dismutase
1
2021
308
0.040
 Why?
Immunophenotyping
3
2007
322
0.040
 Why?
Amino Acid Motifs
2
2014
219
0.040
 Why?
Sickness Impact Profile
1
1999
62
0.040
 Why?
Regression Analysis
2
2007
1001
0.040
 Why?
Drug Combinations
1
2020
396
0.040
 Why?
Capsules
1
2018
42
0.030
 Why?
Survivors
1
2022
523
0.030
 Why?
Herpesviridae Infections
1
1999
148
0.030
 Why?
Cytotoxicity, Immunologic
3
2007
224
0.030
 Why?
Chemoprevention
1
2018
92
0.030
 Why?
Chemistry Techniques, Analytical
1
2018
20
0.030
 Why?
Uganda
1
2018
90
0.030
 Why?
Renal Insufficiency
1
2000
172
0.030
 Why?
Nanomedicine
1
2018
47
0.030
 Why?
Metabolic Clearance Rate
1
2018
115
0.030
 Why?
Oxazines
1
2018
37
0.030
 Why?
Hemophilia A
1
2000
148
0.030
 Why?
Drug Compounding
1
2018
107
0.030
 Why?
Histoplasmosis
1
1997
15
0.030
 Why?
Heart Diseases
2
2000
341
0.030
 Why?
Feasibility Studies
1
2022
1115
0.030
 Why?
Fibrin Fibrinogen Degradation Products
1
2018
92
0.030
 Why?
Fluconazole
1
1997
24
0.030
 Why?
Severity of Illness Index
3
2000
2933
0.030
 Why?
Cardiology Service, Hospital
1
1997
29
0.030
 Why?
Palatine Tonsil
1
2017
54
0.030
 Why?
Adaptation, Physiological
1
2021
560
0.030
 Why?
Inosine Triphosphate
1
2016
2
0.030
 Why?
Cause of Death
1
2019
472
0.030
 Why?
Genotype
3
2012
1857
0.030
 Why?
Early Detection of Cancer
1
2022
486
0.030
 Why?
Models, Theoretical
1
2000
560
0.030
 Why?
Perforin
1
2016
22
0.030
 Why?
Internet
1
2002
693
0.030
 Why?
Aged, 80 and over
2
2021
8347
0.030
 Why?
Clinical Studies as Topic
1
2016
12
0.030
 Why?
Anemia, Hemolytic
1
2016
21
0.030
 Why?
Guanosine Triphosphate
1
2016
89
0.030
 Why?
Primary Health Care
1
2007
1737
0.030
 Why?
Antifungal Agents
1
1997
152
0.030
 Why?
Half-Life
1
2016
155
0.030
 Why?
Lymphocyte Depletion
1
2016
133
0.030
 Why?
Child
7
2017
22740
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2021
1217
0.030
 Why?
Eating
1
1999
387
0.030
 Why?
Nucleotides
1
2016
129
0.030
 Why?
Peru
1
2016
60
0.030
 Why?
Statistics, Nonparametric
2
2012
428
0.030
 Why?
Prognosis
2
2021
4330
0.030
 Why?
Spermatozoa
1
2016
107
0.030
 Why?
Clinical Protocols
1
1997
280
0.030
 Why?
Heart Valve Prosthesis Implantation
1
1998
198
0.030
 Why?
Forkhead Transcription Factors
1
2016
209
0.030
 Why?
Machine Learning
1
2021
587
0.030
 Why?
United States
6
2016
16126
0.030
 Why?
Human Activities
1
2015
20
0.030
 Why?
Randomized Controlled Trials as Topic
1
2022
1752
0.030
 Why?
Algorithms
2
2011
1851
0.030
 Why?
Intubation, Intratracheal
1
1998
327
0.030
 Why?
Piperazines
1
2018
375
0.030
 Why?
Receptors, CXCR4
2
2007
91
0.030
 Why?
Animals
4
2016
38101
0.030
 Why?
Drug Users
1
2015
43
0.030
 Why?
South Africa
1
2016
266
0.030
 Why?
Blood
1
2015
107
0.030
 Why?
Receptors, CCR7
1
2014
32
0.030
 Why?
Receptors, CXCR5
1
2014
27
0.030
 Why?
HEK293 Cells
1
2017
741
0.030
 Why?
Drug Administration Schedule
1
2016
782
0.030
 Why?
Cathelicidins
1
2014
40
0.030
 Why?
Adenosine Triphosphate
1
2016
500
0.030
 Why?
Polymerase Chain Reaction
2
2012
1043
0.030
 Why?
Mutation Rate
1
2014
35
0.030
 Why?
Gene Expression Regulation, Viral
1
2014
93
0.020
 Why?
Substance Abuse, Intravenous
1
2015
127
0.020
 Why?
Child, Preschool
4
2002
11868
0.020
 Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
32
0.020
 Why?
Aging, Premature
1
2013
17
0.020
 Why?
Body Fat Distribution
1
2013
46
0.020
 Why?
Registries
1
2022
2410
0.020
 Why?
Amino Acid Substitution
1
2014
302
0.020
 Why?
Kidney Failure, Chronic
1
1999
599
0.020
 Why?
Energy Metabolism
1
1999
935
0.020
 Why?
Infant
3
2002
10091
0.020
 Why?
Mothers
1
1999
766
0.020
 Why?
Muscles
1
2013
330
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2015
638
0.020
 Why?
Clone Cells
2
2002
263
0.020
 Why?
Infant, Newborn
2
1994
6465
0.020
 Why?
Cyclopropanes
1
2012
84
0.020
 Why?
Alkynes
1
2012
67
0.020
 Why?
Receptors, HIV
1
2011
22
0.020
 Why?
Confidence Intervals
1
2012
330
0.020
 Why?
Cardiac Surgical Procedures
1
1997
611
0.020
 Why?
Insulin-Like Growth Factor I
1
2013
317
0.020
 Why?
Bone and Bones
1
2013
318
0.020
 Why?
Geography
1
2011
187
0.020
 Why?
Disease Susceptibility
1
2012
344
0.020
 Why?
Epithelial Cells
1
2016
1134
0.020
 Why?
Chi-Square Distribution
2
2002
528
0.020
 Why?
North America
1
2011
304
0.020
 Why?
Follow-Up Studies
2
2015
5428
0.020
 Why?
Interleukin-2
2
2003
440
0.020
 Why?
Pregnancy Complications, Infectious
1
1994
440
0.020
 Why?
Depression
1
2019
1559
0.020
 Why?
Bone Density
1
2013
487
0.020
 Why?
Cell Proliferation
1
2016
2514
0.020
 Why?
Cost-Benefit Analysis
1
2012
644
0.020
 Why?
Body Mass Index
2
2013
2447
0.020
 Why?
Postoperative Complications
1
2001
2977
0.020
 Why?
Postoperative Hemorrhage
2
2000
105
0.020
 Why?
United States Department of Veterans Affairs
2
2004
779
0.020
 Why?
DNA, Viral
2
2000
356
0.020
 Why?
Respiratory Tract Diseases
2
2000
175
0.020
 Why?
Socioeconomic Factors
1
2012
1327
0.020
 Why?
Health Status
2
2004
835
0.020
 Why?
Gene Expression Regulation
1
2016
2601
0.020
 Why?
Magnetic Resonance Imaging
1
2000
3916
0.020
 Why?
Immunosuppressive Agents
1
2012
838
0.020
 Why?
DNA Primers
1
2008
505
0.020
 Why?
Personnel Turnover
1
2007
40
0.020
 Why?
Lymphocyte Count
1
2007
165
0.020
 Why?
Sweating
1
2007
43
0.020
 Why?
Risk Assessment
3
2004
3752
0.010
 Why?
Gender Identity
1
2007
129
0.010
 Why?
Hospital Mortality
2
2004
1038
0.010
 Why?
Health Care Surveys
1
2007
536
0.010
 Why?
Fever
1
2007
320
0.010
 Why?
DNA
1
2012
1437
0.010
 Why?
Selection Bias
1
2005
38
0.010
 Why?
Obesity
1
1999
3118
0.010
 Why?
Quality Indicators, Health Care
1
2007
336
0.010
 Why?
Base Sequence
1
2008
2171
0.010
 Why?
Acute Disease
1
2007
1036
0.010
 Why?
Cell Line
2
2001
2823
0.010
 Why?
HLA-A3 Antigen
1
2003
6
0.010
 Why?
HLA-B7 Antigen
1
2003
7
0.010
 Why?
HLA-A2 Antigen
1
2003
36
0.010
 Why?
Neoplasms
1
2019
2913
0.010
 Why?
Superantigens
1
2003
70
0.010
 Why?
Histocompatibility Testing
1
2003
123
0.010
 Why?
Cell Line, Transformed
1
2003
138
0.010
 Why?
Intraoperative Care
1
2004
63
0.010
 Why?
Virus Activation
1
2003
94
0.010
 Why?
B7-2 Antigen
1
2002
27
0.010
 Why?
Postoperative Period
1
2004
351
0.010
 Why?
Double-Blind Method
1
2008
2064
0.010
 Why?
Drug Evaluation, Preclinical
1
2003
196
0.010
 Why?
Chronic Disease
1
2009
1812
0.010
 Why?
Morbidity
1
2004
322
0.010
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.010
 Why?
Hospital-Physician Relations
1
2002
4
0.010
 Why?
Parainfluenza Virus 3, Human
1
2002
5
0.010
 Why?
Community Medicine
1
2002
7
0.010
 Why?
Rotavirus
1
2002
21
0.010
 Why?
CD40 Antigens
1
2002
90
0.010
 Why?
Attitude to Computers
1
2002
28
0.010
 Why?
Sick Role
1
2001
20
0.010
 Why?
HIV Core Protein p24
1
2001
32
0.010
 Why?
Immunity, Cellular
1
2003
274
0.010
 Why?
Streptococcus pyogenes
1
2002
41
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2003
849
0.010
 Why?
Pregnancy
1
1994
7216
0.010
 Why?
Health Services Research
1
2004
391
0.010
 Why?
Preoperative Care
1
2004
380
0.010
 Why?
Respiratory Syncytial Virus, Human
1
2002
81
0.010
 Why?
Nonlinear Dynamics
1
2001
93
0.010
 Why?
Phosphorus Radioisotopes
1
2000
25
0.010
 Why?
Elbow
1
2000
56
0.010
 Why?
Community-Acquired Infections
1
2002
177
0.010
 Why?
Hyperplasia
1
2000
177
0.010
 Why?
Knee
1
2000
72
0.010
 Why?
Ankle
1
2000
64
0.010
 Why?
Forecasting
1
2001
390
0.010
 Why?
Hemophilia B
1
2000
65
0.010
 Why?
Antigens, CD
1
2002
558
0.010
 Why?
Seasons
1
2002
538
0.010
 Why?
Synovial Membrane
1
2000
124
0.010
 Why?
Calorimetry, Indirect
1
1999
72
0.010
 Why?
Diet Records
1
1999
89
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
1998
49
0.010
 Why?
Fathers
1
1999
53
0.010
 Why?
Cost Control
1
1998
38
0.010
 Why?
Amino Acid Sequence
1
2002
2131
0.010
 Why?
Mice, Transgenic
1
2003
2191
0.010
 Why?
Anthropometry
1
1999
206
0.010
 Why?
Activities of Daily Living
1
2001
444
0.010
 Why?
Erythrocyte Transfusion
1
2000
225
0.010
 Why?
Radiography
1
2000
853
0.010
 Why?
Puberty
1
1999
137
0.010
 Why?
Analysis of Variance
1
2000
1300
0.010
 Why?
Streptokinase
1
1996
9
0.010
 Why?
Phytohemagglutinins
1
1996
29
0.010
 Why?
Reproducibility of Results
1
2005
3418
0.010
 Why?
Tetanus Toxoid
1
1996
34
0.010
 Why?
Cell Division
1
1998
757
0.010
 Why?
Candida
1
1996
46
0.010
 Why?
Postoperative Care
1
1998
286
0.010
 Why?
Exercise Test
1
1999
630
0.010
 Why?
Antigens, Bacterial
1
1996
126
0.010
 Why?
Disease-Free Survival
1
1997
770
0.010
 Why?
Survival Rate
1
2000
2094
0.010
 Why?
Logistic Models
1
2000
2139
0.010
 Why?
Nuclear Proteins
1
1999
740
0.010
 Why?
Adipose Tissue
1
1999
645
0.010
 Why?
Patient Selection
1
1997
739
0.010
 Why?
Recombinant Proteins
1
1996
1368
0.010
 Why?
Databases, Factual
1
1999
1491
0.010
 Why?
Prevalence
1
1999
2875
0.010
 Why?
Mice
1
2003
18355
0.000
 Why?
MaWhinney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (515) concept(s)
_
Co-Authors Expand Description
See all (74) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)